ES2091283T3 - Derivados de isocromano. - Google Patents

Derivados de isocromano.

Info

Publication number
ES2091283T3
ES2091283T3 ES91201119T ES91201119T ES2091283T3 ES 2091283 T3 ES2091283 T3 ES 2091283T3 ES 91201119 T ES91201119 T ES 91201119T ES 91201119 T ES91201119 T ES 91201119T ES 2091283 T3 ES2091283 T3 ES 2091283T3
Authority
ES
Spain
Prior art keywords
alkyl
hydrogen
group
alkoxy
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91201119T
Other languages
English (en)
Inventor
Jean-Claude Laigle
Michel Combourieu
Nadine Simbille
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2091283T3 publication Critical patent/ES2091283T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76—Benzo[c]pyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A UN DERIVADO DE ISOCROMANO QUE TIENE LA FORMULA GENERAL I EN QUE R SUB 1 ES DE UNO A CUATRO SUSTITUYENTES INDEPENDIENTEMENTE SELECCIONADOS DE HIDROGENO, HIDROXI, ALQUILO (1-4 C), ALCOXI (1-4 C), HALOGENO O CF SUB 3 O COMO DOS SUSTITUYENTES ADYACENTES JUNTOS UN GRUPO METILENODIOXI; R SUB 2 ES DE UNO A CUATRO SUSTITUYENTES INDEPENDIENTEMENTE SELECCIONADOS DE HIDROGENO, HIDROXI, ALQUILO (1-4 C), ALCOXI (1-4 C), HALOGENO O CF SUB 3 O COMO DOS SUSTITUYENTES ADYACENTES JUNTOS UN GRUPO METILENODIOXI; R SUB 3 ES DE UNO A CUATRO SUSTITUYENTES INDEPENDIENTEMENTE SELECCIONADOS DE HIDROGENO, HIDROXI, ALQUILO (1-4 C), ALCOXI (1-4 C), HALOGENO O CF SUB 3 O COMO DOS SUSTITUYENTES ADYACENTES JUNTOS UN GRUPO METILENODIOXI; R SUB 4 ES SELECCIONADO DE HIDROGENO O ALQUILO (1-4 C); A ES UN ENLACE DE UN GRUPO DE ALQUILENO O DE ALQUILIDENO CON DE 1 A 6 ATOMOS DE CARBONO; B ES UN GRUPO DE ALQUILENO O DE ALQUILIDENO CON 1 A 6 ATOMOS DE CARBONO CUANDO Y ES UN ENLACE O B ES UN GRUPO DE ALQUILENO CON DE 2 A 6 ATOMOS DE CARBONO CUANDO Y ES UN GRUPO SELECCIONADO DE O, S O NR SUB 5; X ES CH O N; Y R SUB 5 ES SELECCIONADO DE HIDROGENO O ALQUILO (1-4 C); O UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO. LOS COMPUESTOS PUEDEN SER UTILIZADOS EN EL TRATAMIENTO DE ANGINA DEL PECHO, DISRITMIAS CARDIACAS, CARDIOMIOPATIAS, APOPLEJIA, MUERTE SUBITA E INFARTO DE MIOCARDIO.
ES91201119T 1990-05-25 1991-05-10 Derivados de isocromano. Expired - Lifetime ES2091283T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90401407 1990-05-25

Publications (1)

Publication Number Publication Date
ES2091283T3 true ES2091283T3 (es) 1996-11-01

Family

ID=8205714

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91201119T Expired - Lifetime ES2091283T3 (es) 1990-05-25 1991-05-10 Derivados de isocromano.

Country Status (15)

Country Link
EP (1) EP0458387B1 (es)
JP (1) JPH04253970A (es)
KR (1) KR910020004A (es)
AT (1) ATE140001T1 (es)
AU (1) AU643277B2 (es)
CA (1) CA2042861A1 (es)
DE (1) DE69120603T2 (es)
DK (1) DK0458387T3 (es)
ES (1) ES2091283T3 (es)
FI (1) FI912400A (es)
GR (1) GR3021084T3 (es)
IE (1) IE73232B1 (es)
NZ (1) NZ238243A (es)
PT (1) PT97766B (es)
ZA (1) ZA913691B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2176722A1 (en) * 1993-12-28 1995-07-06 Ruth E. Ten Brink Heterocyclic compounds for the treatment of cns and cardiovascular disorders
US6387897B1 (en) 1998-06-30 2002-05-14 Neuromed Technologies, Inc. Preferentially substituted calcium channel blockers
US6310059B1 (en) 1998-06-30 2001-10-30 Neuromed Technologies, Inc. Fused ring calcium channel blockers
US6951862B2 (en) 1998-06-30 2005-10-04 Neuromed Technologies, Inc. Calcium channel blockers comprising two benzhydril moieties
US6492375B2 (en) 1998-06-30 2002-12-10 Neuromed Technologies, Inc. Partially saturated calcium channel blockers
US7186726B2 (en) 1998-06-30 2007-03-06 Neuromed Pharmaceuticals Ltd. Preferentially substituted calcium channel blockers
US6943168B2 (en) 1998-06-30 2005-09-13 Neuromed Technologies Inc. Calcium channel inhibitors comprising benzhydril spaced from piperazine
US6011035A (en) * 1998-06-30 2000-01-04 Neuromed Technologies Inc. Calcium channel blockers
CA2903746C (en) 2013-03-08 2022-08-23 Amy Hauck Newman Potent and selective inhibitors of monoamine transporters; method of making; and use thereof
EP3256466B9 (en) * 2015-02-11 2022-07-27 Sunovion Pharmaceuticals Inc. 1-heterocyclyl isochromanyl compounds and analogs for treating cns disorders
US11365195B2 (en) 2017-11-13 2022-06-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Atypical inhibitors of monoamine transporters; method of making; and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552004A (en) * 1976-05-26 1979-09-05 Takeda Chemical Industries Ltd Isochroman derivatives
EP0450689A1 (en) * 1990-04-02 1991-10-09 Akzo Nobel N.V. New isochromane derivatives

Also Published As

Publication number Publication date
NZ238243A (en) 1992-12-23
PT97766A (pt) 1992-03-31
AU643277B2 (en) 1993-11-11
DE69120603T2 (de) 1997-01-02
FI912400A (fi) 1991-11-26
DK0458387T3 (da) 1996-10-21
EP0458387B1 (en) 1996-07-03
KR910020004A (ko) 1991-12-19
AU7733491A (en) 1991-11-28
FI912400A0 (fi) 1991-05-17
GR3021084T3 (en) 1996-12-31
CA2042861A1 (en) 1991-11-26
JPH04253970A (ja) 1992-09-09
PT97766B (pt) 1998-10-30
EP0458387A1 (en) 1991-11-27
IE73232B1 (en) 1997-05-21
ZA913691B (en) 1992-02-26
IE911589A1 (en) 1991-12-04
DE69120603D1 (de) 1996-08-08
ATE140001T1 (de) 1996-07-15

Similar Documents

Publication Publication Date Title
EA200100755A1 (ru) 4-оксо-1,4-дигидро-3-хинолинкарбоксамиды как антивирусные агенты
LU91196I2 (fr) Picoxystrobin et ses dérivlés pharmaceutiquement acceptables(ACANTO).
MX9203122A (es) Compuestos analogos de distamicina a y composiciones farmaceuticas que los contienen.
ATE24001T1 (de) Substituierte 1-hydroxyethyl-triazolyl-derivate.
EA200100310A1 (ru) Кислородсодержащие гетероциклические соединения
ES2091283T3 (es) Derivados de isocromano.
PE34996A1 (es) Nuevo derivado de pirrocarbazol
ES2043807T3 (es) Compuestos anticancer.
DE69122427T2 (de) Imidazonaphthyridinderivate
ATE96446T1 (de) Estramustin-ester.
ES2065994T3 (es) Beta-dicetonas substituidas.
ATE110721T1 (de) 2-alkyl-3-benzoylbenzofurane und diese enthaltende pharmazeutische zusammensetzungen.
ES2053896T3 (es) 4,5-diariltioimidazoles 2-substituidos antihipercolesterolesmicos.
FI914525A0 (fi) Foerening, anvaendning och framstaellning.
ATE105565T1 (de) Pradimicinderivate.
ES2109936T3 (es) Derivados de piperacina.
FI903967A0 (fi) Nya imidazolderivat.
FR2632522B1 (fr) Nouveaux derives de la phenothiazine, leur preparation et les compositions qui les contiennent
DE68911893D1 (de) Antagonisten von Leukotrien D4.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 458387

Country of ref document: ES